This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://theimmunooncologycurve.substack.com?utm_medium=podcast&utm_campaign=CTA_1">theimmunooncologycurve.substack.com</a>

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit theimmunooncologycurve.substack.com

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://theimmunooncologycurve.substack.com?utm_medium=podcast&amp;utm_campaign=CTA_1" rel="noopener noreferrer">theimmunooncologycurve.substack.com</a>

Episode 3: From Practice to Industry – A Conversation with Agenus’ GI Team

A podcast on next-generation immunotherapy developments against cancer. The Immuno-Oncology Curve is produced by Agenus, a clinical-stage biopharmaceutical company that discovers and develops immunotherapies for cancer. Dr. O’Day is the company’s Chief Medical Officer. Occasionally, guests on the podcast will be paid advisors to Agenus or represent organizations that receive funding from Agenus. <a href="https://theimmunooncologycurve.substack.com?utm_medium=podcast">theimmunooncologycurve.substack.com</a>

Science

Medicine

Health & Fitness

Life Sciences

A podcast on next-generation immunotherapy developments against cancer. The Immuno-Oncology Curve is produced by Agenus, a clinical-stage biopharmaceutical company that discovers and develops immunotherapies for cancer. Dr. O’Day is the company’s Chief Medical Officer. Occasionally, guests on the podcast will be paid advisors to Agenus or represent organizations that receive funding from Agenus. theimmunooncologycurve.substack.com

A podcast on next-generation immunotherapy developments against cancer. The Immuno-Oncology Curve is produced by Agenus, a clinical-stage biopharmaceutical company that discovers and develops immunotherapies for cancer. Dr. O’Day is the company’s Chief Medical Officer. Occasionally, guests on the podcast will be paid advisors to Agenus or represent organizations that receive funding from Agenus. <a href="https://theimmunooncologycurve.substack.com?utm_medium=podcast" rel="noopener noreferrer">theimmunooncologycurve.substack.com</a>

Share Episode 3: From Practice to Industry – A Conversation with Agenus’ GI Team

Sign up to save your podcasts

Episode 3: From Practice to Industry – A Conversation with Agenus’ GI Team

Episode 3: From Practice to Industry – A Conversation with Agenus’ GI Team